Side-by-side comparison of AI visibility scores, market position, and capabilities
GitHub Copilot 20M users; Copilot deployed in 90% of Fortune 100; Azure AI infrastructure serving OpenAI exclusively + 65,000+ enterprise customers. Copilot Studio for enterprise AI agents; $13B invested in OpenAI total.
Microsoft Corporation is a Redmond, Washington-based global technology company — publicly traded on NASDAQ (NASDAQ: MSFT) as an S&P 500 Information Technology component and the world's second-largest publicly traded company by market capitalization (~$3.2 trillion) — providing cloud computing, enterprise software, developer tools, gaming, and AI-integrated productivity applications to businesses, consumers, governments, and developers worldwide through approximately 228,000 employees. In fiscal year 2024 (ending June 2024), Microsoft reported revenue of $245.1 billion (+16% year-over-year), with the Intelligent Cloud segment (Azure cloud platform) generating $105.4 billion (+22%), Productivity and Business Processes (Microsoft 365, Teams, LinkedIn, Dynamics) generating $77.7 billion (+12%), and More Personal Computing (Windows, Xbox, Surface, Search) generating $61.8 billion (+17%). Microsoft completed the $68.7 billion acquisition of Activision Blizzard in October 2023 — the largest gaming acquisition in history — adding Call of Duty, World of Warcraft, Overwatch, Candy Crush, and King's mobile games to the Xbox ecosystem. For fiscal year 2025, Microsoft guided continued 13-15% revenue growth driven by Azure's AI infrastructure demand (Azure AI customers grew 100%+ year-over-year), Microsoft 365 Copilot enterprise AI assistant adoption, and GitHub Copilot developer AI tool revenue. CEO Satya Nadella's "mobile-first, cloud-first" strategy, refined to "AI-first" with the OpenAI partnership, has created Microsoft's most competitive product positioning since the Windows/Office era.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.